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Abstract
In postganglionic sympathetic neurons, the size of the dendritic arbor determines pre-
synaptic convergence, which correlates with tonic activity, and aberrant dendritic mor-
phology is associated with disease. There is, therefore, great interest in understanding 
how dendritic morphology is regulated in these neurons. Early studies established a role 
for target-derived nerve growth factor (NGF) in regulating the size of the dendritic arbor 
of sympathetic neurons in vivo. However, in vitro studies revealed that even in the pres-
ence of optimal concentrations of NGF, rat sympathetic neurons cultured in the absence 
of serum or non-neuronal cells survive and elaborate extensive axonal arbors, but fail 
to form dendrites. Subsequently, it was discovered that bone morphogenetic proteins 
(BMPs) trigger cultured sympathetic neurons to extend a dendritic arbor comparable 
to that of their in vivo counterparts. The goals of this chapter are to: (i) summarize these 
early experiments; (ii) discuss evidence substantiating a role for BMPs in glial-induced 
dendritic growth in vitro and regulation of dendritic growth in vivo; (iii) review what is 
known about the molecular mechanisms by which NGF, BMPs and other factors influ-
ence dendritic arborization of sympathetic neurons; and (iv) identify key data gaps in 
understanding of how dendrites are regulated in sympathetic neurons.
Keywords: afferent input, BMPs, dendrites, neuronal polarity, NGF, p75, reactive 
oxygen species (ROS), Rit, Smad, STAT, sympathetic neurons, target-derived factors
1. Introduction
Differences in dendritic morphology between neurons are a striking feature of the vertebrate 
nervous system with important functional implications. The shape of dendrites influences 
the propagation and integration of postsynaptic potentials [1], and determines presynaptic 
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convergence [2, 3]. These observations coupled with evidence that aberrant dendritic struc-
ture is strongly associated with neurologic disease [4, 5] have generated significant interest in 
understanding how dendrites are regulated.
Postganglionic sympathetic neurons are a well-characterized model for studying dendrite 
development and plasticity [6]. The dendritic arbor of these neurons is relatively complex 
with an average of two to six primary dendrites, depending on the animal species, and mul-
tiple orders of branching [7]. In postganglionic sympathetic neurons, the size of the dendritic 
arbor correlates with not only the number and pattern of synaptic inputs [3, 8], but also tonic 
activity [8, 9]. As is true of central neurons, aberrant morphology of sympathetic neuron den-
drites is associated with disease. For example, dendritic hypertropy of sympathetic neurons 
in stellate and superior cervical ganglia (SCG) is observed in the spontaneously hypertensive 
rat [10, 11], and is thought to contribute to the pathogenesis of hypertension in this model [11]. 
Therapeutic intervention with statins not only decreases sympathetic activity and normal-
izes blood pressure in the spontaneously hypertensive rat [12], but also decreases dendritic 
arborization of both stellate and SCG neurons [13].
In this chapter, we will review what is known about the molecular and cellular mechanisms 
that regulate dendrites in postganglionic sympathetic neurons, and identify key data gaps.
2. Early studies of dendritic growth in sympathetic neurons
The majority of dendritic growth in postganglionic sympathetic neurons occurs during 
the postnatal period; however, dendrites continue to grow into adulthood [14–16], and in 
situ imaging of mature sympathetic neurons has demonstrated that their dendritic arbors 
continually grow and retract throughout life [17, 18]. In the rat, neonatal deafferentation 
has negligible effect on dendritic growth in SCG neurons throughout the first month of 
life [19–21], indicating that dendritic growth in sympathetic neurons does not require affer-
ent input. In contrast, target tissues strongly influence dendritic growth in these neurons. 
Experimentally reducing target size causes dendritic arbors of SCG neurons to be smaller 
than normal; conversely, increasing the target size significantly increases the size of the 
dendritic arbor [16]. The influence of target is further illustrated by observations that sym-
pathetic neurons within the same ganglion that project to different targets exhibit varying 
dendritic morphologies [18, 19].
The effect of target tissues on dendritic growth in sympathetic neurons is mediated, at least 
in part, by nerve growth factor (NGF) [22–25]. Separation of neurons from target tissues by 
axonal ligation causes dendritic atrophy in the few neurons that survive, and this effect is 
attenuated by systemic administration of NGF [26, 27]. However, exogenous NGF reverses 
axotomy-induced dendritic retraction by <50%, even though cell survival is completely res-
cued [27], indicating that additional target-derived factors are needed to fully account for the 
effects of target on dendritic growth. Consistent with this conclusion, the dendritic complex-
ity of axotomized sympathetic neurons recovers to control levels upon ganglion cell reinner-
vation of the periphery [28]. In vitro studies further suggest that factors in addition to NGF are 
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required for dendritic growth in sympathetic neurons. When grown in low-density cultures 
in the absence of serum or non-neuronal cells, but in the presence of optimal concentrations 
of NGF, sympathetic neurons form an axon but no dendrites [29, 30].
In vitro studies have further revealed that the initiation and maintenance of dendritic growth 
in sympathetic neurons is regulated by trophic interactions. Addition of serum to NGF-
containing medium stimulates sympathetic neurons to form dendrites, although under these 
culture conditions, the dendritic arbor is significantly less complex than is observed in vivo 
[31]. In contrast, co-culture with ganglionic glial cells causes these neurons to form a dendritic 
arbor comparable to that of their in vivo counterparts [32]. Subsequently, it was discovered 
that the addition of bone morphogenetic proteins (BMPs) to the culture medium similarly 
triggers sympathetic neurons to form a complex dendritic arbor [29, 33]. Multiple BMP family 
members have been shown to stimulate dendritic growth in cultured sympathetic neurons, 
including BMPs 2, 4, 5, 6, 7 and 60A; however, this activity appears to be restricted to the dpp 
and 60A BMP subfamilies since BMP-3 and other members of the TGFβ superfamily, includ-
ing TGFβ1, TGFβ2, TGFβ3, activin A, inhibin, and GDNF, have no effect on dendritic growth 
in cultured sympathetic neurons [29, 33, 34].
The trophic actions of BMPs are specific to dendritic growth in that BMPs do not support cell 
survival, nor do they enhance axonal growth in cultured sympathetic neurons [29]. Consistent 
with observations of dendritic growth in sympathetic neurons in vivo, the dendrite-promoting 
activity of BMP-7 is independent of synaptic or electrical activity [35], but is modulated by 
NGF [29, 36]. Importantly, the dendritic arbor induced by BMPs in cultured sympathetic 
neurons is comparable to that of their in vivo counterparts with respect to not only size and 
complexity, but also accumulation and post-translational modification of dendrite-specific 
cytoskeletal and membrane proteins, exclusion of axonal proteins, transport of select mRNA, 
and formation of synaptic contacts of the appropriate polarity [29, 34, 35]. These observations 
indicate that BMPs selectively induce the execution of a developmental program in sympa-
thetic neurons that controls both quantitative and qualitative aspects of dendritic growth.
These observations suggest that BMPs mediate the effects of ganglionic glia and target tissues 
on dendritic growth in sympathetic neurons. Immunocytochemical and in situ hybridization 
studies indicate that the spatiotemporal expression of BMPs 5, −6, and −7 in rat SCG is consis-
tent with a role in the initial stages of dendritogenesis [33, 37]. In vitro, both SCG glia and neu-
rons express BMP mRNA and protein when grown in the absence or presence of each other 
[37]. However, co-culture of sympathetic neurons with ganglionic glia markedly increases 
BMP protein coincident with a significant decrease in levels of the soluble BMP antagonists, 
follistatin and noggin [37]. Functional assays indicate that glial-induced dendritic growth is 
significantly reduced by BMP-7 antibodies and completely blocked by exogenous noggin and 
follistatin [37]. Collectively, these data suggest a model in which glia influence the rapid peri-
natal expansion of the dendritic arbor in sympathetic neurons by increasing BMP activity via 
modulation of the balance between BMPs and their antagonists. Whether this model holds 
true in vivo has yet to be tested.
The question of whether BMPs also contribute to target effects on dendritic growth has yet to 
be addressed experimentally. Sympathetic targets, including the eye, heart, lung, kidney, and 
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blood vessels, express significant levels of BMPs during embryonic development, throughout 
the postnatal period, and into adulthood [38–40]. Thus, target tissues may be a source of 
BMPs to sympathetic neurons not only during initial expansion of the dendritic arbor, but 
also in the maintenance and remodeling of dendritic arbors that continues throughout the life 
of the animal.
3. Signaling pathways that regulate dendritic growth in sympathetic 
neurons
Research over the past few decades has provided insights into the signaling pathways and 
molecular mechanisms that control dendritic growth in sympathetic neurons. As discussed 
in the preceding section, BMPs and NGF play predominant roles in the initiation and mainte-
nance of dendrites in these autonomic neurons. While the importance of these growth factors 
as regulators of dendritic growth in sympathetic neurons is well established, the downstream 
effectors that link BMP and NGF to increased dendritic growth are not fully understood. In 
this section, we will discuss the signaling pathways activated by these growth factors, the 
evidence implicating downstream effectors of BMPs and NGF in dendritic regulation, and the 
identification of factors that interact with these signaling pathways to alter their influence on 
the dendritic arborization of sympathetic neurons.
3.1. BMP signaling
BMPs mediate their cellular effects by binding to a heteromeric receptor complex of trans-
membrane serine/threonine kinas receptor subunits comprised of a type I receptor [BMP type 
I receptor A (BMPR1A), which is also known as activin receptor-like kinase-3 (ALK-3) or BMP 
type I receptor B (BMPRIB, also known as ALK-6)], and a type II receptor [BMP type II recep-
tor (BMPRII), activin type II receptor (ActRII), or activin type IIB receptor (ActRIIB)] [41, 42]. 
Ligand binding causes type II receptors to phosphorylate type I receptors, which then phos-
phorylate Smads 1, 5, and/or 8, also known as receptor Smads (R-Smads). Phosphorylated 
R-Smads complex with Smad 4, triggering translocation of the Smad complex to the nucleus 
to regulate gene transcription [42, 43]. Studies in Smad knockout animals and Smad deficient 
cells suggest that BMPs can also signal through Smad-independent pathways via activation 
of mitogen-activated protein kinase (MAPK), c-jun amino terminal kinase (JNK), p38-MAPK, 
phosphoinositol-3-kinase (PI3K), LIM kinase 1 (LIMK1) or small GTPases [43–46].
BMP signaling pathways are active in sympathetic ganglia during developmental periods 
corresponding to the initiation, extension and maintenance of dendrites. Quantitative PCR, in 
situ hybridization, and immunocytochemistry studies have confirmed the presence of mRNA 
and protein for BMPRIA, BMPRIB, ActRII and BMPRII in neurons of mouse SCG starting as 
early as embryonic day 14, and persisting into postnatal development and even adulthood 
[47, 48]. A role for BMPRIA in regulating dendritic growth in sympathetic neurons in vivo 
was confirmed in a BMPRIA conditional knockout mouse generated by crossing a Dbhi-Cre 
mouse line to a BmprIa floxed line [49]. Dbhi-Cre is expressed in sympathetic ganglia around 
E10.5, thus, BmprIa expression is knocked out after neuronal specification, but before initia-
tion of dendritic growth. The loss of BMPRIA expression in sympathetic ganglia significantly 
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diminished but did not completely block dendritic growth in vivo [49]. At postnatal day 3, the 
number of primary dendrites and the size of the dendritic arbor were not significantly differ-
ent in sympathetic neurons of SCG from BmprIa conditional knockout mice vs. SCG neurons 
from congenic wildtype controls. At later developmental times, however, dendritic arboriza-
tion was significantly decreased in SCG neurons of BmprIa knockout vs. wildtype mice. These 
data suggest that, in vivo, BMP signaling is required for the maintenance of dendrites, but not 
for the initiation and early growth of dendrites in sympathetic neurons.
Several caveats of the in vivo study suggest that the lack of effect of BmprIa knockout on early 
stages of dendritic growth in vivo may not be discrepant with in vitro data showing that BMPs 
are necessary and sufficient for induction of dendritic growth in sympathetic neurons [29, 49]. 
First, while the authors confirmed that BmprIa mRNA was not generated in the SCG after 
embryonic day 11.5, they did not examine BMPRIA protein levels in the SCG of knockout 
animals. Thus, the possibility that BMPRIA protein was still present during early stages of 
dendritic growth cannot be ruled out. Moreover, recent biochemical studies have shown that 
BMPRs cycle between various cellular compartments, and the association of the receptors 
with endocytosis machinery is required for Smad-mediated signal transduction [50]. Thus, 
additional studies are needed to characterize BMPR turnover and changes in receptor local-
ization in wildtype vs. BMPR knockouts. Another, perhaps more likely, explanation is that 
sympathetic neurons in the BmprIa knockout mice express other type I receptors, such as the 
activin receptors, that may be activated by BMPs to trigger dendritic growth at early develop-
mental stages. Further studies targeting other BMPRs are warranted to fully elucidate the role 
of BMP signaling in dendritogenesis in vivo.
3.1.1. Smad-dependent transcriptional regulation of dendritic growth
Canonical BMP signaling involves the Smad family of transcription factors. Immunocyto-
chemical analyses of primary rat SCG neurons have demonstrated that Smad 1/5/8 translocates 
to the nucleus within 20 minutes of exposure to BMP-7, with maximal nuclear translocation 
observed within 2 hours of adding BMP-7 to the culture medium. Transfection with a Smad1 
dominant negative mutant, Smad1 (3SA), blocked BMP-7-induced dendritic growth in pri-
mary sympathetic neurons [51], indicating that Smad 1 activation is necessary for induction 
of dendritic growth by BMP-7. In contrast to the BmprIa conditional knockouts, conditional 
knockdown of Smad4 in sympathetic neurons, generated by crossing Dbhi-Cre mice to Smad4 
floxed mice, increased dendritic length and the size of the dendritic arbor in SCG neurons 
[49], suggesting that Smad 4 may play a role in limiting dendritic growth in vivo.
A comprehensive analyses of Smad-dependent dendritic growth in sympathetic neurons pro-
vided evidence for early transcriptional regulation of dendritic growth downstream of BMP-7 
[52]. In neuronal cell cultures from embryonic rat SCG, BMP-7-induced dendritic growth 
could be blocked by pharmacologic inhibition of transcription with actinomycin-D when the 
inhibitor was added within the first 24 hours of BMP-7 exposure but not when it was added 
after 48 hours of BMP-7 exposure. Microarray analyses identified over 250 genes that were 
differentially regulated by BMP-7 within the first 24 hours after adding BMP-7 to the culture 
medium. Of these, 56 mRNAs were altered within the first 6 hours and 185 mRNAs were dif-
ferentially regulated at 24 hours after BMP exposure [52]. Many of the differentially regulated 
genes were linked to signaling pathways previously implicated in dendritogenesis in other 
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neuronal cell types or neuronal morphogenesis and/or axonal guidance, such as BMP, Notch, 
integrin, Wnt, and NGF signaling molecules. However, the functional relevance of most of 
these genes to dendritic growth in sympathetic neurons has yet to be determined. Moreover, 
recent reports of limited correlation between transcriptome and proteome analysis in yeast, 
plants and mice [53, 54], suggest that in order to generate a more complete understanding of 
the molecular pathways that link BMPs to dendritic growth in sympathetic neurons, detailed 
proteome analyses are needed to complement the existing transcriptomic dataset.
One gene identified as being strongly upregulated by BMP-7 in primary sympathetic neu-
rons, the gene encoding the p75 neurotrophin receptor (p75NTR) [52], has been evaluated for a 
role in BMP-induced dendritic growth. A member of the tumor necrosis factor (TNF) receptor 
family, p75NTR regulates diverse neurobiological processes, including axonal growth, synaptic 
plasticity, dendritic growth in central neurons, and neuronal cell death [55–61]. p75NTR binds 
diverse ligands to mediate its effects, including NGF, other neurotrophins, myelin-derived 
polypeptides, such as myelin-associated glycoprotein (MAG) or Nogo, and β-amyloid peptide 
[60, 62, 63]. In cultured embryonic rat SCG neurons, p75NTR mRNA and protein expression are 
significantly upregulated within 24 hours of exposure to BMP-7 [52, 64], and pharmacologic 
inhibition of signaling via BMPRI prevents induction of p75NTR protein expression in primary 
sympathetic neurons exposed to BMP-7 [64]. Functional studies revealed that BMP7 does 
not trigger dendritic growth in primary sympathetic neurons derived from SCG of p75NTR 
knockout mice; conversely, ligand-independent activation of p75NTR via overexpression of a 
p75NTR cDNA construct in p75NTR−/− neurons [65], phenocopies the dendrite-promoting effects 
of BMP-7 [64]. Morphometric analyses of SCG from wildtype vs. p75NTR knockout mice at 3, 
6 and 12–16 weeks of age indicated that genetic deletion of p75NTR does not prevent dendritic 
growth, but does significantly stunt dendritic maturation in sympathetic neurons. These data 
support the hypotheses that p75NTR is involved in downstream signaling events that mediate 
BMP7-induced dendritic growth in sympathetic neurons, and suggest that p75NTR signaling 
positively modulates dendritic complexity in sympathetic neurons in vivo.
An outstanding question regarding p75NTR effects on dendritic growth in sympathetic neurons 
is the identity of ligand(s) and co-receptor(s) that p75NTR interacts with to mediate BMP-induced 
dendritic growth. Several lines of evidence argue against a direct interaction between p75NTR 
and the BMP receptor complex: (i) inhibiting transcription blocks both BMP-induced dendritic 
growth and upregulation of p75NTR mRNA [52]; (ii) pharmacologic blockade of BMPRI signal-
ing blocks p75NTR induction [64]; and (iii) overexpressing p75NTR in cultured p75NTR−/− neurons 
induces dendritic growth even in the absence of BMP-7 [64]. NGF is a potential activating 
ligand, and NGF is required for BMP-induced dendritic growth [29, 36]. However, the obser-
vation that p75NTR interactions with the primary receptor for NGF, TrkA, serve to limit synapse 
formation in sympathetic neurons [66], argues against p75NTR-TrkA interactions enhancing 
dendritic development. Likewise, pro-neurotrophin activation of the p75NTR-sortilin complex 
serves to promote sympathetic axon degeneration and cell death [67], suggesting that this 
interaction is also unlikely to stimulate dendritic growth. The identity of the p75NTR ligand that 
mediates BMP-7-induced dendritic growth remains an outstanding question.
Similarly, the downstream effector molecule(s) that link p75NTR to increased dendritic arbori-
zation remain to be determined. Key candidates include the Rho GTPases. Rho GTPases func-
tion as central regulators of dendritic morphology, linking extracellular signals to changes 
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in the dendritic actin cytoskeleton [68, 69]. p75NTR has been shown to interact with RhoA in 
the yeast two-hybrid system [70]. In cultured rat sympathetic neurons, exposure to BMP-7 
increases the levels of the GTP-bound form of RhoA, but not GTP-Rac1 or GTP-Cdc42, as 
determined by a GTP pull down assay, and triggers RhoA translocation from the cytoplasm 
to the membrane [13]. The observation that BMP-7-induced dendritic growth in primary sym-
pathetic neurons requires RhoA activation [13], suggests a model in which BMP-7 sequen-
tially activates BMPRIA, Smad 1/5/8, p75NTR, and then RhoA to induce dendritic growth in 
sympathetic neurons.
3.2. Signaling pathways that interact with Smad signaling to modulate BMP-
induced dendritic growth
The shape of the dendritic arbor of developing sympathetic neurons is determined by interac-
tions between positive and negative regulators of dendritic growth. A number of signaling 
pathways have been shown to interact with BMP signaling to modulate the number of den-
drites, total dendritic length and dendritic branching in sympathetic neurons. In this section, 
we will review known positive and negative regulators of Smad signaling that impact BMP-
induced dendritogenesis in sympathetic neurons.
3.2.1. Positive regulators of Smad signaling that enhance dendritic growth
Proteasome-mediated signaling. The ubiquitin-proteasome pathway is unique in that it is one 
of the few signaling pathways identified thus far whose interactions with BMP signaling 
enhance dendritic arborization in sympathetic neurons. In the nervous system, proteasome-
mediated protein degradation pathways are important for self-renewal of neurons, axonal 
growth, vesicle release, receptor turnover, signal transduction and synaptic plasticity [71–
73]. The ubiquitin-proteasome pathway has been implicated in regulating dendritic growth 
in the mammalian central nervous system, with multiple E3 ubiquitin ligases, including 
Anaphase promoting complex (APC), cullin RING-type E3 ubiquitin ligases (CUL) and neu-
ronal precursor cell expressed and developmentally downregulated protein (Nedd4), deter-
mined to be necessary for the extension and maintenance of the dendritic arbor of central 
neurons [71, 74–76].
Biochemical studies have shown that R-Smads interact with components of the proteasome 
complex, as well as enzymes and proteins involved in the ubiquitination-deubiquitination of 
proteins, in many systems, and the ability of Smads to regulate transcription is dependent on 
association with the proteasome complex in various cell types [77, 78]. Interactions between 
BMP signaling molecules and the proteasome pathway have been reported in perinatal rat 
sympathetic neuronal cultures prior to dendritic growth induction by BMP-7 [51]. In this 
study, interactions between Smad1 and multiple proteasome components were confirmed 
using a yeast two-hybrid assay, and pharmacologic inhibition of proteasome activity by lac-
tacystin and ALLN (N-acetyl-Leu-Leu-norleucinal) selectively blocked BMP-7-induced den-
dritic growth in primary sympathetic neurons in the absence of any effect on axonal growth 
[51]. These proteasome inhibitors also suppressed Smad-mediated transcriptional regulation 
in a biochemical assay using a Tlx -luciferase construct transfected into P19 cells [51]. One 
caveat of this study is that although there was clearly a functional interaction between BMP 
signaling and the proteasome pathway in the context of dendritic growth, a biochemical 
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interaction between Smads and proteasomes were not demonstrated in primary sympathetic 
neurons. Further studies are necessary to fully understand the genetic and biochemical inter-
actions between Smads and ubiquitin-proteasome pathway during dendritogenesis in sym-
pathetic neurons.
Signaling mediated by reactive oxygen species (ROS). Under physiological conditions, ROS are 
generated by the mitochondrial electron transport chain or as a consequence of the activity of 
NADPH oxidase (NOX) [79–81]. While the deleterious effects of ROS at high concentrations 
are well documented, over the past decade, there is growing appreciation of the beneficial 
role of ROS at physiological concentrations [80–84], and of the importance of the NOX family 
of enzymes in regulating many aspects of neuronal development including neurogenesis, 
neurite outgrowth and synaptic plasticity [80, 83, 85]. NOX2 is expressed in neonatal rat 
SCG neuronal cell cultures [86], and exposure of cultured embryonic SCG neurons to BMP-7 
increases the expression of NOX2 [87]. Pharmacologic inhibition or siRNA knockdown of 
NOX2 significantly decreases BMP-7-induced dendritic growth in primary sympathetic neu-
rons, an effect that is also observed in cultures co-exposed to BMP-7 and any of three mecha-
nistically and structurally distinct antioxidants that block ROS generation [87]. Antioxidants 
block BMP-induced dendritic growth downstream of Smad signaling since BMP-induced 
nuclear translocation of Smads is unaffected by antioxidant treatment [87].
Collectively, these data support the hypothesis that ROS are involved in the downstream sig-
naling events that mediate BMP7-induced dendritic growth, and suggest that ROS-mediated 
signaling positively modulates dendritic complexity in sympathetic neurons. One caveat of 
this study, however, is that while BMP-7 was observed to increase NOX2 levels and oxygen 
consumption in sympathetic neurons, increased ROS levels were not detected in sympathetic 
neurons exposed to BMP-7. Likely, this reflects the fact that physiologic BMP signaling gener-
ates levels of ROS that are below the detection threshold for standard ROS detection assays. 
Further work is needed to determine whether these in vitro observations translate to a role for 
ROS in regulating dendritic growth in sympathetic ganglia in vivo.
3.2.2. Negative regulators of SMAD signaling that influence dendritic growth
STAT signaling. The interferons (IFN) and the neuropoietic cytokines, which include inter-
leukins (IL), leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF), sig-
nal through the activation and nuclear translocation of signal transducers and activators 
of transcription (STAT) proteins, which then regulate transcription of target genes [88]. 
Previous studies have shown that cytokines that signal through STATs vs. members of the 
TGFβ superfamily of signaling molecules tend to exert opposing effects on cellular function 
[89–91]. Similar antagonistic interactions between STAT-dependent cytokine signaling path-
ways and the BMP signaling pathways have been documented during dendritogenesis in 
perinatal sympathetic neurons. In primary perinatal sympathetic neurons, addition of LIF, 
CNTF or gamma-IFN (IFNγ) significantly decreased the number of primary dendrites and 
total dendritic length in cultures exposed to BMP-7, but had no effect on axonal growth or cell 
viability [92–94]. In addition, all three cytokines triggered retraction of preexisting dendrites 
[92, 94], suggesting a role for them in the dendritic retraction observed following neuronal 
injury. Addition of LIF, CNTF or IFNγ to primary sympathetic neurons resulted in nuclear 
translocation of STAT, and transfection of a dominant negative STAT1 construct blocked 
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IFNγ-mediated dendritic retraction [92, 94]. These data provide evidence that neuropoietic 
cytokines negatively regulate dendritic growth in perinatal sympathetic neurons via activa-
tion of STAT proteins. However, many questions remain, including the mechanism by which 
nuclear translocation of STAT proteins limits the activity of SMAD proteins, and the down-
stream targets of STAT and SMAD signaling during dendritogenesis.
Mitogen-activated protein kinase (MAPK) signaling. MAPK family members, including extra-
cellular signal-regulated kinase (ERK), p38, and c-Jun NH
2
-terminal kinase (JNK), are ser-
ine–threonine kinases that function as downstream effectors of many extracellular signaling 
molecules, including NGF, epidermal growth factor (EGF), and fibroblast growth factor (FGF) 
[95, 96]. The activation of MAPK regulates gene expression to alter various cellular activities 
such as cell division, growth, survival and cell death [95, 96]. Previous studies in Xenopus 
embryos and cells such as radial glia, astrocytes, hippocampal neurons, and PC12 cells, have 
demonstrated interplay between Smad and MAPK signaling pathways, and shown that phos-
phorylation of the linker on the Smad protein by MAPK is necessary for coordinating the 
cellular effects of BMPs and other growth factors [43, 97–99]. Interplay between BMP and 
MAPK signaling pathways is also observed during dendritogenesis in rat and mouse sympa-
thetic neurons. Pharmacologic inhibition of MAPK signaling with PD98059 or transfection of 
a dominant negative MEK1 or ERK2 mutant increases the number of dendrites and total den-
dritic arbor induced following BMP-7 exposure, whereas overexpression of MEK1 decreases 
BMP-7 induced dendritic growth [100]. Inhibition of MAPK signaling in primary sympathetic 
neurons also increases Smad nuclear accumulation following BMP-7 exposure, and FGF was 
identified as one of the ligands responsible for activating the ERK signaling pathway in these 
neurons [100]. These findings suggest that, in perinatal sympathetic neurons, FGF activates 
the MAPK pathway, which inhibits the nuclear accumulation of SMADs, thereby limiting 
BMP-induced dendritic growth.
In addition to modulating BMP effects on dendritic arborization via activation of MAPK sig-
naling, FGFs regulate neuronal differentiation via the integrative nuclear FGFR1 signaling 
(INFS) pathway [101]. FGFR1 is expressed in the nucleus of adult rat SCG neurons following 
axotomy [102]. Nuclear localization of FGFR1 is also increased in perinatal rat sympathetic 
neurons following exposure to BMP-7, and transfection of a mutant FGFR1 receptor inhibits 
FGFR1 nuclear localization and decreases the dendritic response to BMP-7 [103]. These data 
suggest that the INFS-mediated FGF signaling pathway functions downstream of BMP sig-
naling to limit BMP-induced dendritogenesis in sympathetic neurons.
Rit GTPase, a member of the small GTPase family, has also been shown to activate ERK1/2 in 
primary sympathetic neurons, and the transfection of dominant negative (dn) Rit or consti-
tutively active (ca) Rit were observed to increase or decrease BMP-induced dendritic growth, 
respectively [36]. Rit GTPase also negatively modulates dendritic growth as a downstream 
target of IFNγ signaling as demonstrated by inhibition of IFNγ-mediated dendritic retraction 
in primary sympathetic neurons transfected with dnRit constructs [104]. Addition of IFNγ to 
cultures of pheochromocytoma cells, which are often used as a model for sympathetic neu-
rons, increased levels of GTP-Rit, and transfection of dnRit inhibited IFNγ-induced activation 
of p38 MAPK [104]. These observations suggest that a novel Rit-p38 MAP kinase signaling 
pathway functions in parallel with the canonical JAK–STAT signaling pathway to mediate 
IFNγ-induced dendritic retraction. Collectively, these studies provide evidence for crosstalk 
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between BMP signaling and MAPK signaling during dendritogenesis in sympathetic neu-
rons, and suggest that in contrast to its effects in central neurons, MAPK signaling functions 
as a negative regulator of BMP-induced dendritic growth in sympathetic neurons.
Retinoic acid signaling. In the developing nervous system, BMPs and retinoic acid work syner-
gistically to regulate neural tube patterning and specification of neuronal identity [105–108]. 
Similarly, interplay between BMP and retinoic acid signaling have been documented during 
dendritogenesis in sympathetic neurons; however, their interaction in this latter context is 
antagonistic [106]. Genes required for synthesis of retinoic acid are expressed in cultured 
perinatal rat SCG neurons, and retinoids synthesized by SCG explants were able to activate 
transcriptional reporters in retinoic acid-responsive F9 cells [106]. The addition of retinoic 
acid, or specific retinoic acid receptor and retinoid X receptor agonists, to the medium of 
cultured sympathetic neurons inhibited BMP-induced dendritic growth without altering 
axonal growth or cell viability [106]. What is not known, however, is the point of conver-
gence between these two pathways in the context of dendritic growth. Further studies are also 
needed to determine whether retinoic acid regulates the dendritic arborization of sympathetic 
neurons in vivo.
Signaling by pituitary adenylate cyclase (PACAP) and vasoactive intestinal peptide (VIP). PACAP is 
a member of the secretin/VIP family of peptides that regulates the development of cells within 
the sympathoadrenal lineage [109]. In sympathetic neurons, PACAP regulates cell survival, 
proliferation, and catecholamine secretion, and release of PACAP and VIP from pregangli-
onic neurons stimulates depolarization of sympathetic neurons [109]. In cultured perinatal 
rat sympathetic neurons, PACAP38 and VIP decrease BMP-induced dendritic growth, as 
evidenced by a decrease in the percentage of cells with dendrites, number of dendrites per 
neuron, and size of the dendritic arbor [110]. Using receptor specific antagonists and antibod-
ies against phosphorylated cyclic AMP response element binding (CREB) protein, the PACAP 
response was shown to be mediated by PAC
1
 receptor activation, which results in the nuclear 
accumulation of phospho-CREB. Inhibition of adenylate cyclase activity by SQ22526 over-
comes the inhibitory effects of PACAP on dendritic growth, and agents that increase cAMP 
levels, such as forskolin, inhibit BMP-induced dendritic growth [110]. These data suggest 
that peptides released by preganglionic nerves modulate dendritic growth in postganglionic 
sympathetic neurons by a cAMP-dependent mechanism.
In summary, signaling by cytokines, growth factors, small molecules, and peptides, such as 
retinoic acid, PACAP and VIP, antagonize BMP signaling during dendritogenesis in sympa-
thetic neurons. Most of the relevant data were collected from studies of primary perinatal 
sympathetic neurons cultured from rodent SCG. While the findings from this model have 
provided a glimpse into the complexity of the interactions that influence dendritic arboriza-
tion of these neurons, further studies are required to understand the mechanisms by which 
these factors interact to regulate dendritic growth, how these pathways are spatially and tem-
porally coordinated to influence dendritic arborization of sympathetic neurons in vivo, and to 
determine their relevance to the human condition.
3.3. Other pathways that regulate dendritic growth in sympathetic neurons
As described earlier, NGF is an important regulator of dendritic growth in sympathetic neu-
rons. However, the molecular mechanisms by which NGF regulates dendritic growth are 
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not well characterized. Early growth response-3 (Egr3), a transcriptional regulator known 
to be induced by NGF via MAPK signaling, has been identified as a potential downstream 
regulator of NGF-induced dendritic growth [111]. Sympathetic neurons from a conditional 
Egr3 knockout generated using Dbhi-Cre have fewer primary dendrites and shorter dendritic 
arbors compared to sympathetic neurons from congenic wildtype animals. In addition, Egr3 
knockout animals exhibit defects in axonal guidance, and in innervation of autonomic targets 
[111]. Although, Egr3 had previously been shown to not be required for NGF effects on neu-
ronal survival [112], some neuronal cell death was observed in germline mutants for Egr3. It 
is, therefore, possible that the dendritic effects of knocking out Egr3 are secondary to adverse 
effects on neuronal cell viability or changes in target innervation.
Neuronal depolarization induced by electric field stimulation or the addition of potassium 
chloride to primary postnatal sympathetic neurons cultured was shown to trigger the forma-
tion of dendrites in the presence of NGF that retracted in the absence of neuronal activity 
[113]. Neuronal depolarization enhanced stability of microtubules and activated calcium 
calmodulin dependent kinase II (CaMKII) in dendrites. The latter was shown to be causally 
related to the effects of neuronal depolarization on dendritic growth: pharmacologic inhibi-
tion of CaMKII activity using KN62 or mAIP completely blocks activity-dependent dendritic 
growth in cultured sympathetic neurons [113].
Signaling by integrin-linked kinase (ILK) and glycogen synthase kinase-3β (GSK-3β) have also 
been shown to be downstream effectors of activity-dependent dendritic growth in postnatal 
sympathetic neurons [114]. ILK and GSK-3β are serine threonine kinases that are downstream 
effectors of integrin and neurotrophin signaling [115]. ILK has been shown to phosphorylate 
and inactivate GSK-3β to regulate NGF-mediated axonal growth [116]. Increased phosphory-
lation of GSK-3β protein was observed in cultured postnatal rat SCG neurons in response to 
increased neuronal activity, and inhibition of ILK activity by QLT0254, as well as transfection 
of dominant negative ILK or siRNA for ILK, blocked activity-dependent dendritic growth in 
these neurons. Similarly, inhibition of GSK-3β activity using kenpaullone or genetic knock-
down of GSK-3β expression increased the number of primary dendrites formed in response to 
potassium chloride, suggesting that GSK-3β inhibition is necessary for early stages of activity-
dependent dendritic growth in sympathetic neurons.
Interestingly, unlike BMP-induced dendritic growth, inhibition of ERK activity inhibited 
activity-dependent dendritic growth in postnatal sympathetic neurons in vitro [113, 114]. 
Pharmacologic inhibition of ERK by PD98059 blocked activity-dependent dendritic growth, 
inhibition of GSK-3β increased depolarization-dependent ERK activation, and inhibition of 
ERK reversed the enhanced dendritic growth observed with GSK-3β inhibition [113, 114]. 
The reasons for the opposing roles of ERK in BMP-induced vs. activity-dependent dendritic 
growth remain unexplored.
4. The path forward
The experimental evidence clearly implicate NGF, BMP and neuronal activity as positive 
regulators of dendritic growth in perinatal sympathetic neurons in vitro. However, the inter-
action between these three pathways and their relative contributions to the induction and 
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maintenance of dendritic growth in sympathetic neurons in vivo are not fully understood. 
Multiple mechanistically and structural diverse signaling molecules have been implicated 
as negative regulators of dendritic growth in vitro. The spatial and temporal regulation of 
these pathways, how they interact with each other and with positive modulators of dendritic 
growth to shape dendritic arbors, and their functional significance in vivo remain outstanding 
questions. In addition, further studies are needed to understand the genes and proteins that 
are regulated downstream of each of these signaling pathways and to identify those that serve 
as hubs for interactions between multiple signaling pathways to regulate the final dendritic 
arbor of sympathetic neurons. Finally, a key data gap is the relevance of these observations in 
experimental models to the human condition.
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